News

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to ...
A health expert has shared what is the only carbohydrate you can eat that won't cause your blood glucose to spike. Addressing ...
Flax seeds are superfoods that are packed with a nutritional punch. Incorporating flax seeds into your meals can boost your overall health and well-being.
What if I told you there’s a wall at the edge of our solar system? 😱🚀 Scientists have detected a mysterious cosmic boundary ...
World Liver Day is an opportunity to spread awareness about mindful eating, healthy food for the liver, and screening in case ...
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
Living with diabetes doesn’t mean you can’t enjoy Easter treats and traditions. You might try food swaps or alternatives with ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...